These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34854250)

  • 21. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of prognostic signature of non-small cell lung cancer based on TCGA methylation data.
    Wang Y; Wang Y; Wang Y; Zhang Y
    Sci Rep; 2020 May; 10(1):8575. PubMed ID: 32444802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
    Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
    Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M; Jiang Q; Jin R
    IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
    Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
    Zhu XF; Zhu BS; Wu FM; Hu HB
    J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro.
    Yao Q; Yu Y; Wang Z; Zhang M; Ma J; Wu Y; Zheng Q; Li J
    BMC Cancer; 2022 Jan; 22(1):117. PubMed ID: 35090419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG methylation signature predicts prognosis in breast cancer.
    Du T; Liu B; Wang Z; Wan X; Wu Y
    Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.
    Li M; Zhang C; Zhou L; Li S; Cao YJ; Wang L; Xiang R; Shi Y; Piao Y
    Mol Oncol; 2020 Nov; 14(11):2744-2758. PubMed ID: 32688456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model.
    Sun N; Chu J; Hu W; Chen X; Yi N; Shen Y
    Sci Rep; 2022 Jan; 12(1):27. PubMed ID: 34996932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation markers of surfactant proteins in lung cancer.
    Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
    Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.
    Ke H; Wu Y; Wang R; Wu X
    Med Sci Monit; 2020 Oct; 26():e925833. PubMed ID: 33021972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma.
    Wang J; Yu XF; OUYang N; Luo QL; Zhao SY; Guan XF; Chen T; Li JX
    J Toxicol Environ Health A; 2019; 82(1):37-45. PubMed ID: 30626254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations.
    Kuo IY; Jen J; Hsu LH; Hsu HS; Lai WW; Wang YC
    J Biomed Sci; 2016 Aug; 23(1):58. PubMed ID: 27484806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
    Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
    J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.